Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis

By afschroeder • February 3, 2026

Pikoulas A, Morianos I, Nidris V, Hamdy R, Intze E, López-López Á, Moran-Garrido M, Muthu V, Halabalaki M, Papaioanou V, Papadovasilaki M, Kyrmizi I, Gu Y, Camunas-Alberca SM, Aerts R, Mercier T, Vanbiervliet Y, Cho SY, Spallone A, Jiang Y, Samonakis D, Kastritis E, Lax C, Tzardi M, Eliopoulos A, Georgila K, Carvalho A, Kurzai O, Rudramurthy SM, Elie C, Lanternier F, Petratos K, Garre V, Drakos E, Maertens J, Bruno VM, Kontoyiannis DP, Barbas C, Soliman SSM, Ibrahim AS, Chamilos G. Author Correction: Albumin orchestrates a natural host defence mechanism against mucormycosis. Nature. 2026 Feb 2. doi: 10.1038/s41586-026-10188-1. Epub ahead of print. Erratum for: Nature. 2026 Jan;649(8097):693-702. doi: 10.1038/s41586-025-09882-3. PMID: 41629703.

Tags: Harbor UCLA, Infectious Diseases, Post Doc, Publications

Efficacy and safety of relacorilant for the treatment of patients with Cushing’s syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study

Pivonello R, Arnaldi G, Auchus RJ, Badiu C, Busch RS, Cannavò S, Dischinger U, Dobri GA, Donegan DM, Elenkova A, Fazeli PK, Feelders RA, Garcia-Centeno[...]

A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid and Lymphoid Leukemias

Chan B, Balar E, Villalona S, Karp J, Leahy A, Lai C. A Review of Patient-Reported Outcomes and Clinical Outcomes in Acute and Chronic Myeloid[...]

Aspirin use, lipoprotein(a), and calcific aortic valve disease: the Multi-ethnic Study of Atherosclerosis

Razavi AC, Bhatia HS, Marrero N, Dzaye O, Post WS, Nasir K, Tsai M, Vaccarino V, Vasan RS, Thanassoulis G, Tsimikas S, Sperling LS, Budoff[...]